ConductScience.org, home

Paper38425919

Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy.

Zhou P and 10 others. JACS Au, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy. Papers, record 38425919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38425919

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mapping Spatiotemporal Heterogeneity in Multifocal Breast Tumor Progression by Noninvasive Ultrasound Elastography-Guided Mass Spectrometry Imaging Strategy.
PubMed
Journal
JACS Au
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.96, provisional
iCite
Revised in PubMed
2024-03-02
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou PPeng
2Xiao YYu
3Zhou XXin
4Fang JJinghui
5Zhang JJingwen
6Liu JJianjun
7Guo LLing
8Zhang JJiuhong
9Zhang NNinghttps://orcid.org/0000-0002-6161-5469
10Chen KKe
11Zhao CChaohttps://orcid.org/0000-0002-1765-6423

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131139713Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression.ACS Cent Sci2019https://conductscience.org/library/papers/31139713PubMed
230814649Identification of bioactive metabolites using activity metabolomics.Nat Rev Mol Cell Biol2019https://conductscience.org/library/papers/30814649PubMed
334646386Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer.Theranostics2021https://conductscience.org/library/papers/34646386PubMed
433652221Breast cancer proliferation and deterioration-associated metabolic heterogeneity changes induced by exposure of bisphenol S, a widespread replacement of bisphenol A.J Hazard Mater2021https://conductscience.org/library/papers/33652221PubMed
524985940Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment.Trends Cell Biol2014https://conductscience.org/library/papers/24985940PubMed
617035995Phosphoinositides in cell regulation and membrane dynamics.Nature2006https://conductscience.org/library/papers/17035995PubMed
721062159Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Future Oncol2010https://conductscience.org/library/papers/21062159PubMed
833188273Crosstalk between mechanotransduction and metabolism.Nat Rev Mol Cell Biol2021https://conductscience.org/library/papers/33188273PubMed
919669618The glycerophosphoinositols: cellular metabolism and biological functions.Cell Mol Life Sci2009https://conductscience.org/library/papers/19669618PubMed
1027821323Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.Eur J Cancer2016https://conductscience.org/library/papers/27821323PubMed
1131548545Breast cancer.Nat Rev Dis Primers2019https://conductscience.org/library/papers/31548545PubMed
1229731990Ceramide species are elevated in human breast cancer and are associated with less aggressiveness.Oncotarget2018https://conductscience.org/library/papers/29731990PubMed
1334901900Mass spectrometry imaging-based multi-modal technique: Next-generation of biochemical analysis strategy.Innovation (Camb)2021https://conductscience.org/library/papers/34901900PubMed
1436633187Divide and Conquer: A Flexible Deep Learning Strategy for Exploring Metabolic Heterogeneity from Mass Spectrometry Imaging Data.Anal Chem2023https://conductscience.org/library/papers/36633187PubMed
1535686331Advances in high-resolution mass spectrometry techniques for analysis of high mass-to-charge ions.Mass Spectrom Rev2023https://conductscience.org/library/papers/35686331PubMed
1637164974Signaling pathways in cancer metabolism: mechanisms and therapeutic targets.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37164974PubMed
1719279183Ceramide synthases and ceramide levels are increased in breast cancer tissue.Carcinogenesis2009https://conductscience.org/library/papers/19279183PubMed
1833235291Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.Oncogene2021https://conductscience.org/library/papers/33235291PubMed
1920876798De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation.Cancer Res2010https://conductscience.org/library/papers/20876798PubMed
2023235911Ceramide-orchestrated signalling in cancer cells.Nat Rev Cancer2013https://conductscience.org/library/papers/23235911PubMed

See all 48 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41826648Metabolic networks in the tumor microenvironment: roles of amino acid and lipid metabolism pathways in cancer progression and therapy.Exp Mol Med2026https://conductscience.org/library/papers/41826648PubMed
40723225Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets.Cancers (Basel)2025https://conductscience.org/library/papers/40723225PubMed
40197022MSIght: A Modular Platform for Improved Confidence in Global, Untargeted Mass Spectrometry Imaging Annotation.J Proteome Res2025https://conductscience.org/library/papers/40197022PubMed
39484162Cancer metabolic reprogramming and precision medicine-current perspective.Front Pharmacol2024https://conductscience.org/library/papers/39484162PubMed
39437423Recent Developments in Single-Cell Metabolomics by Mass Spectrometry─A Perspective.J Proteome Res2025https://conductscience.org/library/papers/39437423PubMed
39285904Microplastome visualizations: From spatiotemporal distribution to risk assessment.Innovation (Camb)2024https://conductscience.org/library/papers/39285904PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NBEAL223218PubTator's text mininghttps://conductscience.org/library/genes/23218

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38425919

GET https://conductscience.org/api/papers/v1/38425919/references?page=2